लोड हो रहा है...

At baseline patients treated with esketamine have higher burden of disease than other patients with treatment resistant depression: Learnings from a population based study

INTRODUCTION: It is critical to assess who is being treated with a new marketed drug like esketamine to understand how it is used in the real‐world setting and the effects of the medication. METHODS: Retrospective analysis using two large U.S. health care databases that included commercially insured...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Depress Anxiety
मुख्य लेखकों: Cepeda, M. Soledad, Kern, David M., Canuso, Carla M.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: John Wiley and Sons Inc. 2021
विषय:
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC8248018/
https://ncbi.nlm.nih.gov/pubmed/33475213
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/da.23138
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!